SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A,
BIB 70.25+0.1%Nov 6 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jibacoa who wrote (407)10/8/2003 3:28:22 PM
From: JMarcus  Read Replies (1) of 3722
 
AVGN appears to me to have broken out of its trading range, which had been capped by resistance at the $6.00 level from January and earlier:

finance.yahoo.com

I'm expecting their intended submission of an IND for their second lead product candidate (for the treatment of Parkinson's disease) prior to the end of 2003 to drive the stock sharply higher, once the submission is achieved.

Marc
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext